Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT04643301
Clinical Trials · NCT04643301
Liraglutide for Low-responders After Bariatric Surgery
Withdrawn
N/A
Liraglutide
(Prohibited)
Phase
N/A
Recruitment status
Withdrawn
Sponsor
Zuyderland Medisch Centrum
Enrollment
0
Start date
Dec 2020
Locations
See registry
Primary endpoint
%TWL (%TWL)
View Liraglutide compound reference